{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:50:03Z","timestamp":1781027403110,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25-DA037756"],"award-info":[{"award-number":["R25-DA037756"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1UL1TR001430"],"award-info":[{"award-number":["1UL1TR001430"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jsat.2021.108655","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T18:28:10Z","timestamp":1636050490000},"page":"108655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["\u201cNo home to take methadone to\u201d: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston"],"prefix":"10.1016","volume":"135","author":[{"given":"Miriam T.H.","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey M.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel D.","family":"Maschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Bagley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Y.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108655_bb0005","article-title":"Achieving saturation in thematic analysis: Development and refinement of a codebook, comprehensive","volume":"3","author":"Ando","year":"2014","journal-title":"Psychology"},{"issue":"21","key":"10.1016\/j.jsat.2021.108655_bb0010","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2020.6887","article-title":"Prevalence of SARS-CoV-2 infection in residents of a large homeless shelter in Boston","volume":"323","author":"Baggett","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jsat.2021.108655_bb0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0033354920936227","article-title":"Addressing COVID-19 among people experiencing homelessness: Description, adaptation, and early findings of a multiagency response in Boston","volume":"135","author":"Baggett","year":"2020","journal-title":"Public Health Reports"},{"key":"10.1016\/j.jsat.2021.108655_bb0020","article-title":"Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19","volume":"108449","author":"Brothers","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108655_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108444","article-title":"Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects","author":"Buchheit","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108655_bb0030","series-title":"Constructing grounded theory: A practical guide through qualitative analysis","author":"Charmaz","year":"2006"},{"key":"10.1016\/j.jsat.2021.108655_bb0035","author":"Coffin"},{"issue":"3","key":"10.1016\/j.jsat.2021.108655_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/ipm.2020.47","article-title":"Addiction psychiatry and COVID-19: Impact on patients and service provision","volume":"37","author":"Columb","year":"2020","journal-title":"Irish Journal of Psychological Medicine"},{"key":"10.1016\/j.jsat.2021.108655_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1472-6963-14-271","article-title":"Scoping review of patient-centered care approaches in healthcare","volume":"14","author":"Constand","year":"2014","journal-title":"BMC Health Services Research"},{"issue":"10","key":"10.1016\/j.jsat.2021.108655_bb0050","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.2105\/AJPH.2013.301491","article-title":"Effectiveness of case management for homeless persons: A systematic review","volume":"103","author":"de Vet","year":"2013","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2021.108655_bb0055","author":"Drug Enforcement Administration"},{"key":"10.1016\/j.jsat.2021.108655_bb0060","series-title":"The implications of COVID-19 for people who use drugs (PWUD) and drug service providers","author":"EMCDDA","year":"2020"},{"key":"10.1016\/j.jsat.2021.108655_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.abrep.2019.100212","article-title":"Psychiatric symptoms and recent overdose among people who use heroin or other opioids: Results from a secondary analysis of an intervention study","volume":"10","author":"Fendrich","year":"2019","journal-title":"Addictive Behaviors Reports"},{"key":"10.1016\/j.jsat.2021.108655_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108276","article-title":"Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19","volume":"123","author":"Figgatt","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108655_bb0075","first-page":"e1","article-title":"COVID-19 and the drug overdose crisis: Uncovering the deadliest months in the United States, January\u2013July 2020","author":"Friedman","year":"2021","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2021.108655_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102958","article-title":"COVID-19 and the health of people who use drugs: What is and what could be?","volume":"83","author":"Grebely","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.jsat.2021.108655_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13722-021-00221-1","article-title":"Adapting inpatient addiction medicine consult services during the COVID-19 pandemic","volume":"16","author":"Harris","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2021.108655_bb0090","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2003539","article-title":"Virtually perfect? Telemedicine for Covid-19","author":"Hollander","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2021.108655_bb0095","series-title":"The double pandemic of social isolation and COVID-19: Cross-sector policy must address both","author":"Holt-Lunstad","year":"2020"},{"key":"10.1016\/j.jsat.2021.108655_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108219","article-title":"Reimagining patient-centered care in opioid treatment programs: Lessons from the bronx during COVID-19","volume":"122","author":"Joseph","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Suppl. 2","key":"10.1016\/j.jsat.2021.108655_bb0105","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.2105\/AJPH.2013.301481","article-title":"Comparing homeless persons\u2019 care experiences in tailored versus nontailored primary care programs","volume":"103","author":"Kertesz","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.jsat.2021.108655_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247951","article-title":"Understanding the impact of the SARS-COV-2 pandemic on hospitalized patients with substance use disorder","volume":"16","author":"King","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jsat.2021.108655_bb0115","article-title":"Adaptation of a system of treatment for substance use disorders during the COVID-19 pandemic","author":"Komaromy","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2021.108655_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.039","article-title":"Touchpoints\u2014opportunities to predict and prevent opioid overdose: A cohort study","volume":"204","author":"Larochelle","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108655_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2015.04.008","article-title":"Predictors of opioid-related death during methadone therapy","volume":"57","author":"Leece","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108655_bb0130","series-title":"Qualitative data analysis: A methods sourcebook","author":"Miles","year":"2018"},{"key":"10.1016\/j.jsat.2021.108655_bb0135","series-title":"NVivo qualitative data analysis software","author":"NVivo","year":"2012"},{"issue":"1","key":"10.1016\/j.jsat.2021.108655_bb0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12954-021-00508-1","article-title":"\u201cYou know, we can change the services to suit the circumstances of what is happening in the world\u201d: A rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland","volume":"18","author":"Parkes","year":"2021","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.jsat.2021.108655_bb0145","article-title":"Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: Population based retrospective cohort study","volume":"368","author":"Pearce","year":"2020","journal-title":"The BMJ"},{"issue":"26","key":"10.1016\/j.jsat.2021.108655_bb0150","doi-asserted-by":"crossref","first-page":"E716","DOI":"10.1503\/cmaj.200834","article-title":"COVID-19 and people experiencing homelessness: Challenges and mitigation strategies","volume":"192","author":"Perri","year":"2020","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.jsat.2021.108655_bb0155","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.9778\/cmajo.20200287","article-title":"Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: A retrospective cohort study","volume":"9","author":"Richard","year":"2021","journal-title":"CMAJ Open"},{"issue":"1","key":"10.1016\/j.jsat.2021.108655_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12954-021-00471-x","article-title":"Adapting harm reduction services during COVID-19: Lessons from the supervised injecting facilities in Australia","volume":"18","author":"Roxburgh","year":"2021","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.jsat.2021.108655_bb0165","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2021.108655_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108263","article-title":"Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder","volume":"123","author":"Stringer","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108655_bb0175","series-title":"Provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency","author":"Substance Abuse and Mental Health Service Administration","year":"2020"},{"key":"10.1016\/j.jsat.2021.108655_bb0180","series-title":"Opioid treatment program (OTP) guidance","first-page":"1","author":"Substance Abuse and Mental Health Services Administration","year":"2020"},{"key":"10.1016\/j.jsat.2021.108655_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107890","article-title":"Risk and protective factors for repeated overdose after opioid overdose survival","volume":"209","author":"Suffoletto","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.jsat.2021.108655_bb9000","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"International Journal for Quality in Health Care"},{"key":"10.1016\/j.jsat.2021.108655_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108124","article-title":"Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine","volume":"118","author":"Uscher-Pines","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108655_bb0195","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.annemergmed.2017.07.281","article-title":"One-year mortality of opioid overdose victims who received naloxone by emergency medical services","volume":"70","author":"Weiner","year":"2017","journal-title":"Annals of Emergency Medicine"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221003810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221003810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:55:48Z","timestamp":1760039748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221003810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"alternative-id":["S0740547221003810"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108655","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cNo home to take methadone to\u201d: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108655"}}